Open Comment Period to Revise Molecular Testing Guidelines in Lung Cancer Treatment Announced
Several diagnostic associations announced the open comment period for the revised 2018 guideline on molecular testing for lung cancer.
Read MorePosted by Andy Lundin | Aug 22, 2024 | Lung Cancer, Molecular Diagnostics |
Several diagnostic associations announced the open comment period for the revised 2018 guideline on molecular testing for lung cancer.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Unknown Origin & Other Cancer Types |
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MorePosted by Chris Wolski | Aug 7, 2024 | Respiratory Disease |
A new study has found that a blood test can predict which preterm babies will develop chronic lung disease, allowing for earlier diagnosis.
Read MorePosted by Chris Wolski | Aug 5, 2024 | Molecular Diagnostic Analyzers |
Indica Labs’ Lung Macrodissect AI, an AI-powered tool designed to enhance slide macrodissection and molecular pathology workflows.
Read MorePosted by Andy Lundin | Jul 29, 2024 | Lung Cancer |
A new study from OncoHost reveals that its PROphetNSCLC test impacts oncologists’ first-line treatment decisions for metastatic NSCLC.
Read More